Prevalence and potential predictors of incidental prostate Cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era
World Journal of Urology · 2024
DOI: 10.1007/s00345-024-05171-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2024. Verfasst von Francesco Esperto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, via Alvaro del Portillo, 200, Rome, 00128, Italy. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Incidental Findings, Prostatic Hyperplasia, Prostatectomy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Despite advancements in prostate multiparametric magnetic resonance imaging (mpMRI) and fusion biopsy (FB), the management of incidental prostate cancer (IPCa) after surgery for benign prostatic obstruction (BPO) remains unclear. The aim of this retrospective study is to determine the prevalence of IPCa in our cohort and identify potential predictors for its occurrence. METHODS: We enrolled patients underwent TURP or simple prostatectomy for BPO at our high-volume center between January 2020-December 2022. Data on age, pre-operative total PSA (tPSA) and PSA density (PSAd) levels, prostate volume, previous MRI, biopsies, specimen weight, rates of positive tissue slices, ISUP score and three-month tPSA were collected. RESULTS: Of 454 patients with negative digital rectal examination who underwent BPO surgery, 74 patients (16.3%) were found to have IPCa. Of these, 33 patients (44.6%) had undergone previous mpMRI. Among the patients who had mpMRI, 23 had negative mpMRI results for suspected prostate cancer, while 10 had positive mpMRI findings (PIRADS ≥ 3) but no evidence of tumor upon FB. KW analysis indicates that PSAd was statistically associated with higher ISUP score, while at univariable regression analysis negative mpMRI (p = 0.03) was the only potential predictor for IPCa. CONCLUSIONS: Among the ISUP groups, PSAd showed a correlation with the tumor, while negative mpMRI was protective against clinically significant PCa. In the era of mpMRI and FB, the IPCa rates found at our center is higher than reported in existing literature and if it were confirmed with further studies, maybe there is a need for expansion in urology guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, via Alvaro del Portillo, 200, Rome, 00128, Italy.
- Department of Urology, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, via Alvaro del Portillo, 200, Rome, 00128, Italy. loris.cacciatore@unicampus.it.
Zitieren
APA
Esperto, F., Cacciatore, L., Tedesco, F., Raso, G., Minore, A., Testa, A., Ragusa, A., Prata, F., Alcini, A., Salerno, A., Flammia, G. P., Papalia, R., & Scarpa, R. M. (2024). Prevalence and potential predictors of incidental prostate Cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era. World Journal of Urology. https://doi.org/10.1007/s00345-024-05171-2
Vancouver
Esperto F, Cacciatore L, Tedesco F, Raso G, Minore A, Testa A, et al. Prevalence and potential predictors of incidental prostate Cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era. World Journal of Urology. 2024. doi:10.1007/s00345-024-05171-2
BibTeX
@article{Esperto2024,
author = {Esperto, Francesco and Cacciatore, Loris and Tedesco, Francesco and Raso, Gianluigi and Minore, Antonio and Testa, Antonio and Ragusa, Alberto and Prata, Francesco and Alcini, Antonio and Salerno, Annamaria and Flammia, Gerardo Paolo and Papalia, Rocco and Scarpa, Roberto Mario},
title = {Prevalence and potential predictors of incidental prostate Cancer in patients undergoing surgery for Benign Prostatic obstruction: a retrospective study in the MRI era},
journal = {World Journal of Urology},
year = {2024},
doi = {10.1007/s00345-024-05171-2}
}
EUVIMED